インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2024-04-22 | SAMAD, SAM | Executive Vice President & CFO | 普通株式 | 購入 | 24 | $126.25 |
| 2024-04-22 | KUPPUSAMY, KARTHIK | SVP, Clinical Solutions | 普通株式 | 購入 | 45 | $126.25 |
| 2024-04-01 | RING, TIMOTHY M | Director | 普通株式 | 購入 | 311 | $0.00 |
| 2024-03-26 | DELANEY, MARK E | SVP & Chief Commercial Officer | 普通株式 | 売却 | 170 | $128.11 |
| 2024-03-26 | PLEWMAN, PATRICK | SVP for Diagnostic Services | 普通株式 | 売却 | 114 | $128.11 |
| 2024-02-29 | PREVOZNIK, MICHAEL E | SVP & General Counsel | 普通株式 | 売却 | 5,611 | $125.88 |
| 2024-02-29 | DOHERTY, CATHERINE T. | EVP, Regional Businesses | 普通株式 | 売却 | 1,187 | $125.88 |
| 2024-02-28 | SAMAD, SAM | Executive Vice President & CFO | 普通株式 | 売却 | 656 | $126.36 |
| 2024-02-28 | DAVIS, J. E. | Director, CEO and President | 普通株式 | 売却 | 3,216 | $126.36 |
| 2024-02-28 | DAVIS, J. E. | Director, CEO and President | 普通株式 | 売却 | 1,804 | $126.36 |
| 2024-02-28 | DELANEY, MARK E | SVP & Chief Commercial Officer | 普通株式 | 売却 | 225 | $126.36 |
| 2024-02-28 | PLEWMAN, PATRICK | SVP for Diagnostic Services | 普通株式 | 売却 | 228 | $126.36 |
| 2024-02-28 | DOHERTY, CATHERINE T. | EVP, Regional Businesses | 普通株式 | 売却 | 557 | $126.36 |
| 2024-02-28 | PLEWMAN, PATRICK | SVP for Diagnostic Services | 普通株式 | 売却 | 105 | $126.36 |
| 2024-02-28 | DOHERTY, CATHERINE T. | EVP, Regional Businesses | 普通株式 | 売却 | 644 | $126.36 |
| 2024-02-28 | GARDNER, MARK A | SVP of Molecular Gen & Oncol | 普通株式 | 売却 | 262 | $126.36 |
| 2024-02-28 | DEPPE, MICHAEL J | SVP, Corp. Controller & CAO | 普通株式 | 売却 | 52 | $126.36 |
| 2024-02-28 | DEPPE, MICHAEL J | SVP, Corp. Controller & CAO | 普通株式 | 売却 | 57 | $126.36 |